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Background
Dengue is a systemic infection with a wide clinical spec-
trum including asymptomatic, mild undifferentiated den-
gue fever (DF), dengue hemorrhagic fever (DHF) and
dengue with shock syndrome (DSS). Detection of dengue
NS1 antigen (Ag) in acute infection is a valuable tool for
early diagnosis. The purpose of this study was to evaluate
the sensitivity of the Platelia NS1 Ag kit (BioRad®) for the
various forms of DENV infection and assess the potential
role of NS1 Ag as a marker of severity.
Methods
We conducted the study at the Kampong Cham hospital,
Cambodia in 2006 and 2007. After obtaining informed
consent, we randomly collected serum samples and clini-
cal data from dengue clinically suspected patients and
also samples (at day 1 and 7 or at the appearance of
fever) among some patients’ family members to identify
asymptomatic dengue cases.
Results
Among 260 confirmed dengue patients, the overall sen-
sitivity and specificity of NS1 kit were of 57.5% and
100%, respectively. NS1 Ag test combined (no significant
difference in relation with other parameters) with an
in-house MAC-ELISA test significantly increased the
sensitivity to over 85% (p<0.001). NS1 Ag positivity rate
was significantly higher when comparing (1) DF versus
DHF/DSS (p<0.001); (2) primary versus secondary
infection (p=0.001); (3) patient with a viremia > 5 log
versus those with lower viremia (p<0.001); (4) patients
infected with DENV-1 versus the other 3 serotypes
(p<0.05). In asymptomatic dengue cases, the NS1 Ag
positive rate was lower than in dengue patients with
samples collected (within 3 days of fever onset, p=0.002
and all days merged, p=0.053). In multivariate analysis,
DHF/DSS was significantly more frequent in secondary
infection (adjusted OR=6.6, p<0.01) when controlled
with age, sex, day of fever onset, DENV serotype and
viremia. Interestingly, severity was associated with high
NS1 antigen level or DENV-1 infection (adjusted ORs:
0.21 (p=0.002) and 0.083 (p=0.006) respectively).
Conclusion
The overall sensitivity of NS1 Ag detection kit appeared
relatively low; however, sensitivity varied widely depending
on virus serotypes, presence/absence of anti-dengue IgG,
viremia level, disease severity or asymptomatic/symptomatic
infections. Nevertheless, laboratory diagnosis improved
when combining NS1 Ag and MAC-ELISA testing.
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